Bill Gates Funding New ‘Globally Accessible’ Covid Vaccines

52
Bill Gates Funding New ‘Globally Accessible’ Covid Vaccines

Microsoft co-founder Bill Gates is funding the development of a new generation of Covid “vaccines.”

The Bill and Melinda Gates Foundation is funding preclinical research programs and trials for the new experimental “conjugate vaccine” for Covid.

The Gates Foundation and the vaccine’s maker, Inventprise Inc., argue that the conjugation technology platform can be produced far more economically than mRNA vaccines.

They boast that the new injections will be “globally accessible” and rapidly produced in a “highly automated, large-scale manufacturing facility.”

So far, the only study to promote the claimed success of the conjugation technology platform has come from the Gates Foundation and Inventprise Inc.

It comes amid growing concerns about the safety and effectiveness of the current Covid mRNA shots.

The mRNA vaccines, heavily touted early on and during the pandemic presented durability challenges.

The experimental injections have also been found to carry far greater risks from adverse events than the virus they’re supposed to be tackling.

Midway through the pandemic even Bill Gates himself, a major investor in BioNTech, declared that what was needed were vaccines that block transmission.

However, mRNA vaccines were found to have little to no effect on transmission.

Gates even referred to the Omicron variant as a vaccine.

The Redmond, Washington-based Inventprise funded a study into the new “conjugate vaccine.”

The authors of the study were unsurprisingly upbeat about the new vaccines.

The study’s participating investigators were either affiliated with Redmond-based Inventprise or the National Research Council of Canada.

Published in SSRN, the study states that “vaccine candidates induce broad cross-protection against several VOC, a characteristic lacking in early mRNA COVID-19 vaccines.”

The study was led by Ivan A. Olave, a Rutgers-trained Ph.D. in biochemistry.

Olave is also the Vice President of Viral Vaccines at Inventprise, Inc.

In the paper for the study, which has not yet been peer-reviewed, the researchers claim:

“Together, this demonstrates a vaccine with remarkably broad cross-protection and potential to protect for extended periods despite mutations, without requiring expensive boosters or antigen adaption.

“These techniques can be applied to more recent SARS-Cov-2 strains, and other viruses, highlighting the benefits of protein-protein conjugation.

“Such vaccines could be produced in our highly automated, large-scale manufacturing facility enabling economical production of inexpensive, effective vaccines for high-need areas.”

They don’t explain the urgent need for a new Covid vaccine, however.

The news comes amid growing pushback against another new Covid “vaccine” promoted by Gates.

As THAIMBC News reported, tens of thousands of Japan’s citizens have been flooding the streets in protest over the government’s push for new self-amplifying “replicon” mRNA “vaccines.”

The experimental “vaccines” recently won approval from Japanese regulators, despite a lack of safety data.

However, renowned experts have been raising the alarm of the new injections.

They are warning that the “self-replicating RNA vaccines” will “trigger a worldwide disaster.”

The Bill Gates-promoted self-amplifying mRNA shots contain the equipment needed to make more of itself once it enters cells.

The injections have been dubbed “replicon” vaccines because they are able to replicate inside the human body to produce more mRNA over time.

Japanese citizens fear they are being used as guinea pigs ahead of a global rollout of the injections.

Meanwhile, experts in the Netherlands are also raising concerns about the “replicon” injections.

A group of leading Dutch scientists and virologists has just made a disturbing discovery about the new Bill Gates-funded “self-amplifying mRNA” vaccines.

The researchers found that the replicon vaccines can form “unwanted and dangerous connections” with other deadly viruses in people who have been vaccinated.

The replicon “vaccines” were rolled out for public use in Japan this month.